Maximilian Mair: Translating the theranostic concept to neurooncology

Maximilian Mair, Resident in Medical Oncology and Postdoctoral Fellow, shared a post by The Lancet Oncology, on X:

“Excited to share our European Organisation for Research and Treatment of Cancer BTG Policy Review on the potential of theranostics in NeuroOncology, exploring challenges and opportunities indeveloping targeted radionuclide therapies and opening new avenues towards personalized care in glioma, meningioma, brainmets and more.”

Quoting for The Lancet Oncology’s post:

“New Policy Review:

Translating the theranostic concept to neurooncology: disrupting barriers.

Authors:  Nathalie L Albert,  Emilie Le Rhun,  Giuseppe Minniti,  Maximilian J Mair,  Norbert Galldiks, Nelleke Tolboom, Asgeir S Jakola, Maximilian Niyazi, Marion Smits, Antoine Verger,  Francesco Cicone, Michael Weller, Matthias Preusser.

Source: Maximilian Mair/X and The Lancet Oncology/X